Recently, in a 6-week randomized controlled trial, we showed that the glucagon-like peptide 1 receptor agonist (GLP-1RA) liraglutide is superior to bile acid sequestration (considered standard-of-care) using colesevelam in reducing BAD symptoms
Your journey begins with a one-on-one consultation where our providers review your health history, lifestyle, and weight goals
European Journal of Clinical Investigation, 38 (10), 743751
Currently, the FDA approval for oral semaglutide as a weight loss treatment is specifically indicated for adults aged 18 and older
The move could significantly expand access to these treatments for people with diabetes and obesity
Victoza (liraglutide): A daily GLP-1 with a much shorter half-life of 13 hours, clearing from the system within 2-3 days of stopping